@article{94db3582e3144fbbb03c0928a808f772,
title = "ACR Appropriateness Criteria{\textregistered} Radiologic Management of Portal Hypertension",
abstract = "Cirrhosis is a heterogeneous disease that cannot be studied as a single entity and is classified in two main prognostic stages: compensated and decompensated cirrhosis. Portal hypertension, characterized by a pathological increase of the portal pressure and by the formation of portal-systemic collaterals that bypass the liver, is the initial and main consequence of cirrhosis and is responsible for the majority of its complications. A myriad of treatment options exists for appropriately managing the most common complications of portal hypertension, including acute variceal bleeding and refractory ascites. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.",
keywords = "AUC, Appropriate Use Criteria, Appropriateness Criteria, Hepatorenal syndrome, Portal hypertension, Refractory ascites, Upper gastrointestinal bleeding, Variceal bleeding",
author = "{Expert Panels on Interventional Radiology and Vascular Imaging} and Pinchot, {Jason W.} and Kalva, {Sanjeeva P.} and Majdalany, {Bill S.} and Kim, {Charles Y.} and Osmanuddin Ahmed and Asrani, {Sumeet K.} and Cash, {Brooks D.} and Jens Eldrup-Jorgensen and Kendi, {A. Tuba} and Scheidt, {Matthew J.} and Sella, {David M.} and Dill, {Karin E.} and Hohenwalter, {Eric J.}",
note = "Funding Information: Dr Ahmed reports personal fees from Cook Medical, grants and personal fees from Canon Medical, personal fees from Cardiva Medical, Argon Medical, Boston Scientific, Genentech, Johnson and Johnson, outside the submitted work. Dr Kalva reports personal fees from Springer, Elsevier, Boston Scientific, Medtronic Inc, Penumbra Inc, grants from Angiodynamics, BD, personal fees from Dova Pharmaceuticals, US Vascular, Koo Foundation, GE Healthcare, Althea Health, grants from NIH, outside the submitted work. Dr Kim reports personal fees from Boston Scientific,BD, outside the submitted work. The other authors state that they have no conflict of interest related to the material discussed in this article. All authors are non-partner/non-partnership track employees. Funding Information: Dr Ahmed reports personal fees from Cook Medical, grants and personal fees from Canon Medical, personal fees from Cardiva Medical, Argon Medical, Boston Scientific, Genentech, Johnson and Johnson, outside the submitted work. Dr Kalva reports personal fees from Springer, Elsevier, Boston Scientific, Medtronic Inc, Penumbra Inc, grants from Angiodynamics, BD, personal fees from Dova Pharmaceuticals, US Vascular, Koo Foundation, GE Healthcare, Althea Health, grants from NIH, outside the submitted work. Dr Kim reports personal fees from Boston Scientific,BD, outside the submitted work. The other authors state that they have no conflict of interest related to the material discussed in this article. All authors are non-partner/non-partnership track employees. Publisher Copyright: {\textcopyright} 2021 American College of Radiology",
year = "2021",
month = may,
doi = "10.1016/j.jacr.2021.02.013",
language = "English (US)",
volume = "18",
pages = "S153--S173",
journal = "Journal of the American College of Radiology",
issn = "1546-1440",
publisher = "Elsevier BV",
number = "5",
}